Inhaled β2-adrenergic receptor agonist (unspecified)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Inhaled β2-adrenergic receptor agonist (unspecified), covering 2025-11-18 to 2025-11-18. Get the full timeline:
Most recent: Clinical Trial Update: the Inhaled β2-adrenergic Receptor Agonist for Transient Tachypnoea of the Newborn (the REFSAL Trial) [Phase 3]